SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Jefferies Initiates Coverage On ORIC Pharmaceuticals with Buy Rating, Announces Price Target of $40

Jefferies initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $40.

Benzinga · 05/19/2020 11:42

Jefferies initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy rating and announces Price Target of $40.